20.01.2015 Views

Introduction to Enzyme and Coenzyme Chemistry - E-Library Home

Introduction to Enzyme and Coenzyme Chemistry - E-Library Home

Introduction to Enzyme and Coenzyme Chemistry - E-Library Home

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Enzymatic Hydrolysis <strong>and</strong> Group Transfer Reactions 97<br />

HO<br />

HO<br />

HO<br />

ENZ<br />

peptide-NH<br />

O<br />

N<br />

R<br />

H 2<br />

peptide-NH<br />

H<br />

N<br />

OH<br />

R<br />

peptide-NH<br />

N<br />

R<br />

hydrolysis products<br />

Figure 5.18 18 O exchange via a hydrate intermediate.<br />

observed at up <strong>to</strong> 10% of the rate of the forward reaction. Since the reaction is<br />

in practice irreversible, this exchange is consistent with the reversible formation<br />

of a hydrated intermediate, as shown in Figure 5.18.<br />

D 2 O solvent iso<strong>to</strong>pe eVects of 1.5–3.2 have been measured under a range of<br />

conditions, consistent with base-catalysed attack of water being the Wrst step<br />

of the mechanism. Finally, small inverse 15 N iso<strong>to</strong>pe eVects have been measured<br />

for the departing nitrogen a<strong>to</strong>m, suggesting pro<strong>to</strong>nation of nitrogen in the ratedetermining<br />

step of the mechanism. The proposed mechanism is illustrated in<br />

Figure 5.19.<br />

According <strong>to</strong> this mechanism Asp-25 acts as a base <strong>to</strong> depro<strong>to</strong>nate an<br />

attacking water molecule, with Asp-25 0 acting as a general acid, forming the<br />

hydrated intermediate. Breakdown of this intermediate with pro<strong>to</strong>nation of<br />

the departing nitrogen a<strong>to</strong>m by the pro<strong>to</strong>nated Asp-25 completes the catalytic<br />

cycle.<br />

Most of the research eVort on the HIV-1 protease has been directed <strong>to</strong>wards<br />

synthesising potent inhibi<strong>to</strong>rs. Given the precedented inhibition of pepsin <strong>and</strong><br />

other aspartyl proteases by pepstatin, a range of substrate analogues containing<br />

statine-like groups have been synthesised <strong>and</strong> found <strong>to</strong> act as potent inhibi<strong>to</strong>rs<br />

for the HIV-1 protease. It is thought that the statine unit mimics the tetrahedral<br />

intermediate formed in the reaction, as shown in Figure 5.20.<br />

Administration of human T-lymphocyte cells that are infected with the<br />

HIV-1 virus with such inhibi<strong>to</strong>rs has demonstrated that these compounds<br />

HO<br />

HO<br />

HO<br />

peptide-NH<br />

H<br />

O<br />

O<br />

Asp ' 25<br />

O<br />

N<br />

O R<br />

H<br />

H<br />

− O O<br />

Asp 25<br />

peptide-NH<br />

H<br />

O − O<br />

Asp ' 25<br />

N<br />

O OH<br />

H<br />

O<br />

R<br />

O<br />

Asp 25<br />

peptide-NH<br />

H<br />

O<br />

O<br />

Asp ' 25<br />

O<br />

OH<br />

− O<br />

HN<br />

R<br />

O<br />

Asp 25<br />

Figure 5.19 Mechanism for HIV-1 protease.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!